Gene Expression Profile of the Human Colorectal Carcinoma LoVo Cells Treated With Sporamin and Thapsigargin

Chun Yang; Si-Jia Chen; Bo-Wen Chen; Kai-Wen Zhang; Jing-Jie Zhang; Rong Xiao; Peng-Gao Li

doi:10.3389/fonc.2021.621462

Gene Expression Profile of the Human Colorectal Carcinoma LoVo Cells Treated With Sporamin and Thapsigargin

Front Oncol. 2021 May 25:11:621462. doi: 10.3389/fonc.2021.621462. eCollection 2021.

Authors

Chun Yang^{1

2

3}, Si-Jia Chen^{1

2

3}, Bo-Wen Chen^{1

2

3}, Kai-Wen Zhang^{1

2

3}, Jing-Jie Zhang^{1

2

3

4}, Rong Xiao^{1

2

3}, Peng-Gao Li^{1

2

3}

Affiliations

¹ School of Public Health, Capital Medical University (CMU), Beijing, China.
² Beijing Key Laboratory of Environmental Toxicology, CMU, Beijing, China.
³ Beijing Key Laboratory of Clinical Epidemiology, CMU, Beijing, China.
⁴ National Center for Child Nutriment Quality Supervision and Testing, China National Children's Center, Beijing, China.

Abstract

Sporamin, a proteinase inhibitor isolated from the sweet potato (Ipomoea batatas), has shown promising anticancer effect against colorectal cancer (CRC) in vitro and in vivo but its mechanisms of action are poorly understood. In the present study, high throughput RNA sequencing (RNA-seq) technology was applied to explore the transcriptomic changes induced by sporamin in the presence of thapsigargin (TG), a non-12-O-tetradecanolphorbol-13-acetate type cancer promoter, in the LoVo human CRC cells. Cellular total RNA was extracted from the cells after they were treated with vehicle (CTL), 1 μM of thapsigargin (TG), or 1 μM of TG plus 30 μM of sporamin (TGSP) for 24 h. The migratory capacity of the cells was determined by wound healing assay. The gene expression profiles of the cells were determined by RNA-seq on an Illumina platform. GO enrichment analysis, KEGG pathway analysis, protein-protein interaction (PPI) network construction, and transcription factors (TF) prediction were all performed based on the differentially expressed genes (DEGs) across groups with a series of bioinformatics tools. Finally, the effect and potential molecular targets of the sporamin at the transcriptome level were evaluated. Sporamin significantly inhibited the migration of cells induced by TG. Among the 17915 genes detected in RNA-seq, 46 DEGs were attributable to the effect of sporamin. RT-PCR experiment validated that the expression of RGPD2, SULT1A3, and BIVM-ERCC5 were up-regulated while NYP4R, FOXN1, PAK6, and CEACAM20 were down-regulated. Sporamin enhanced the mineral absorption pathway, worm longevity regulating pathway, and pyrimidine metabolism pathway. Two TFs (SMIM11A and ATOH8) were down-regulated by sporamin. HMOX1 (up-regulated) and NME1-NME2 (down-regulated) were the main nodes in a PPI network consisting of 16 DEGs that were modulated by sporamin in the presence of TG. Sporamin could favorably alter the gene expression profile of CRC cells, up-regulating the genes that contribute to the homeostasis of intracellular metal ions and the activities of essential enzymes and DNA damage repairment. More studies are warranted to verify its effect on specific genes and delineate the mechanism of action implicated in the process.

Keywords: RNA sequencing; colorectal cancer; gene expression profile; sporamin; thapsigargin; transcriptome.